Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma
Ontology highlight
ABSTRACT: mRNA profiles of tumor plasma cells derived from 40 multiple myeloma patients at diagnosis and at MRD
ORGANISM(S): Homo sapiens
PROVIDER: GSE147165 | GEO | 2021/02/02
REPOSITORIES: GEO
ACCESS DATA